Likewise, in a mouse study of PTEN-driven prostate cancer loss of p53 enhances tumor infiltration of CD11b+Gr1+ polymorphonuclear cells through increased CXCL17 secretion and expansion of immunosuppressive Treg cells [102]. The gene discussed is TP53; the disease is neoplasm.